fincash logo SOLUTIONS
EXPLORE FUNDS
CALCULATORS
LOG IN
SIGN UP

Fincash » Search » Torrent Pharmaceuticals Ltd

Torrent Pharmaceuticals Ltd

Updated on May 26, 2020

Stock/Share Code - TORNTPHARM

Torrent Pharmaceuticals is engaged in one of the leading Indian Pharmaceutical Company engaged in research, development, manufacturing and marketing of generic pharmaceutical formulations.

Below is the details of TORNTPHARM Torrent Pharmaceuticals Ltd

Market Cap₹39,979 Cr.
Current Price ₹2,327 as on 1 Jun 20
52 Week High / Low Price₹2,699 / ₹1,452
Face Value₹5
Stock P/E42.58
Book Value₹302.62
Dividend Yield0.72 %
ROCE13.09 %
ROE14.93 %
Sales Growth (3yrs)1.94 %
SectorPharmaceuticals
IndustryPharmaceuticals - Indian - Bulk Drugs & Formln
Listed onBSE  AND  NSE
Company WebsiteCompany Website
Pros: Company has reduced debt. Company has been maintaining a healthy dividend payout of 38.50%
Cons: Stock is trading at 7.81 times its book value The company has delivered a poor growth of 11.40% over past five years.

Torrent Pharmaceuticals Ltd Price Chart

Torrent Pharmaceuticals Ltd Price Chart

Torrent Pharmaceuticals Ltd Peer Comparison in Pharmaceuticals

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Profit Var % Qtr Sales Var % Sales Qtr Rs.Cr. ROCE %
1. Sun Pharma.Inds. ₹137.85 28.53 ₹113,788.46 Cr. 0.63 ₹399.84 Cr. -2.03 14.25 8184.94 11.19
2. Dr Reddy's Labs ₹3,953.55 33.39 ₹67,652.81 Cr. 0.49 ₹781.1 Cr. 71.52 10.41 4448.90 12.42
3. Cipla ₹642.5 33.79 ₹52,256.4 Cr. 0.46 ₹245.95 Cr. -33.02 -0.63 4376.19 10.94
4. Aurobindo Pharma ₹725.65 16.67 ₹43,690.51 Cr. 0.40 ₹705.45 Cr. -2.26 11.87 5895.00 18.45
5. Biocon ₹385.5 62.53 ₹42,564 Cr. 0.14 ₹123.4 Cr. -42.26 3.41 1581.00 13.39
6. Torrent Pharma. ₹23.95 42.58 ₹39,979.07 Cr. 0.72 ₹168 Cr. 2.44 9.87 1491.00 13.09
7. Cadila Health. ₹349.55 25.02 ₹35,278.17 Cr. 1.02 ₹373.9 Cr. -26.54 1.68 3638.10 15.35
8. Alkem Lab ₹2,282.05 24.26 ₹27,056.36 Cr. 0.97 ₹381.98 Cr. 88.60 13.26 2181.84 16.58

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Torrent Pharmaceuticals Ltd Fundamentals

Quarterly Results

Quarterly reports are issued by companies every three months. Most companies have a financial year-end of Mar. 31 and quarters that end on June 30, Sept. 30, Dec. 31 and March 31.

Standalone Figures in Rs. Crores

Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020
Sales -8471,0251,0401,3321,4521,4721,4811,3571,6031,6031,4711,491
YOY Sales Growth %-36.03%-3.12%-16.73%38.46%71.43%43.61%42.40%1.88%10.40%8.90%-0.68%9.87%
Expenses -7267897811,0401,0401,0161,0301,0631,0911,0711,0231,066
Material Cost %26.09%27.32%23.75%27.63%27.41%25.61%24.58%29.92%26.14%26.58%28.35%25.15%
Employee Cost %22.08%20.20%19.33%17.34%17.36%16.78%17.49%18.87%17.47%16.34%17.81%17.30%
Operating Profit121236259292412456451294512532448425
OPM %14%23%25%22%28%31%30%22%32%33%30%28%
Other Income1099181513410813227311236221
Interest55517111711712012511911711110696
Depreciation747889143141144147147149151152155
Profit before tax10119818083188300192255277393252195
Tax %17%20%89%-165%35%8%5%36%19%17%13%14%
Net Profit8415820220122277182164223328220168
EPS in Rs4.979.311.2512.957.2116.3810.739.7313.1819.4012.979.91
NotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotes

Profit & Loss

The profit and loss (P&L) statement is a financial statement that summarizes the revenues, costs and expenses incurred during a specified period, usually a fiscal quarter or year. The P&L statement is synonymous with the income statement. These records provide information about a company's ability or inability to generate profit" by increasing revenue, reducing costs or both. Some refer to the P&L statement as a statement of profit and loss, income statement, statement of operations, statement of financial results or income, earnings statement or expense statement.

Standalone Figures in Rs. Crores

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019TTM
Sales -9841,1651,4191,7502,0712,7603,3583,4685,4394,5514,2445,7626,168
Sales Growth %11.72%18.44%21.77%23.32%18.31%33.30%21.68%3.26%56.86%-16.33%-6.75%35.77%
Expenses -7839361,0401,3541,6802,0842,2982,6242,9913,4243,3374,1494,251
Material Cost %36.20%36.02%33.05%34.33%38.94%35.49%29.78%31.24%21.74%30.46%26.29%26.81%
Manufacturing Cost %5.13%5.46%5.26%6.36%5.79%5.61%5.94%6.60%4.11%5.44%6.22%4.94%
Employee Cost %11.68%11.43%11.57%15.70%15.09%13.48%12.76%14.82%10.80%15.56%19.62%17.70%
Other Cost %26.60%27.42%23.45%20.98%21.32%20.94%19.94%23.01%18.33%23.77%26.50%22.57%
Operating Profit2012293793963916761,0618432,4481,1279071,6131,917
OPM %20%20%27%23%19%24%32%24%45%25%21%28%31%
Other Income19381859849836306293300332382237
Interest21382939403758173180202294481430
Depreciation33375458647279180213269384579607
Profit before tax1661913143583716659587962,3489555629351,117
Tax %6%2%34%19%16%18%20%22%26%11%14%20%
Net Profit1561872072913115467626231,743854482745939
EPS in Rs8.8910.7011.7616.5417.7030.3643.3534.5794.5950.4728.4844.0555.46
Dividend Payout %19%18%24%23%23%36%22%31%34%28%49%39%

Compounded Sales Growth

  • 10 Years:: 17.33%
  • 5 Years:: 11.40%
  • 3 Years:: 1.94%
  • TTM:: 7.05%

Compounded Profit Growth

  • 10 Years:: 14.10%
  • 5 Years:: -1.16%
  • 3 Years:: -25.16%
  • TTM:: 26.04%

Return on Equity

  • 10 Years:: 23.84%
  • 5 Years:: 14.47%
  • 3 Years:: 24.93%
  • 1 Year:: 50.98%

Balance Sheet

A balance sheet is a financial statement that reports a company's assets, liabilities and shareholders' equity at a specific point in time, and provides a basis for computing rates of return and evaluating its capital structure. It is a financial statement that provides a snapshot of what a company owns and owes, as well as the amount invested by shareholders. It is used alongside other important financial statements such as the income statement and statement of cash flows in conducting fundamental analysis or calculating financial ratios.

Standalone Figures in Rs. Crores

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Share Capital -42424242424285858585858585
Equity Capital42424242424285858585858585
Reserves5436908391,0511,2621,6092,2052,6213,6234,3694,4724,9315,036
Borrowings3424825225725796931,1322,5212,2492,4465,8455,6233,929
Other Liabilities -3094004455576951,0129111,2701,3321,1521,4191,3892,863
Trade Payables164218262299373451480630665548776582710
Advance from Customers123711419000161354213
Other liability items1331451722543025624326406505915895932,153
Total Liabilities1,2361,6151,8482,2222,5783,3564,3336,4977,2898,05111,82012,02711,913
Fixed Assets -4484875265886367918362,7642,6813,5237,4297,4257,220
Gross Block6126817728859871,2041,3213,4163,5324,6348,9059,466
Accumulated Depreciation1651942462973514124856538501,1111,4772,040
CWIP79461054427276508628984473447498513
Investments158245231431478190322434918936625486135
Other Assets -5528379851,1591,4372,0982,6672,6722,7053,1193,3193,6184,045
Inventories1671922283433936976957819701,0321,2991,3581,508
Trade receivables1982412603404108311,3171,1819121,0181,1081,3561,509
Cash Equivalents9818334726536727821870827857238391
Loans n Advances9623216414118223429643552762970044534
Other asset items-7-10-13708658140204214360154221603
Total Assets1,2361,6151,8482,2222,5783,3564,3336,4977,2898,05111,82012,02711,913

Cash Flows

Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow.

Standalone Figures in Rs. Crores

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Cash from Operating Activity -227202307233396-693101,0652,4036769291,232
Profit from operations2232624134254237691,0901,1132,8291,4111,1851,756
Receivables-40-84-55-93-79-583-518-122112-305-170-233
Inventory19-25-36-120-50-3043-87-176-53-183-59
Payables46674790178152-48195128-121230-24
Direct taxes-20-18-62-69-75-103-217-34-490-255-132-208
Other operating items0000000000-00
Cash from Investing Activity --139-31-137-242-142-89-326-2,099-584-527-4,207-373
Fixed assets purchased-121-51-150-241-83-295-364-176-467-472-756-616
Fixed assets sold311211267112
Investments purchased-1900-1-1800000-15-2
Investments sold03981191116103736561
Interest received21811212649281612118
Dividends received00005000000287
Invest in subsidiaries-9-2-8-14-24-7-1000-10
Investment in group cos000-17-610000000
Other investing items40000153-1-1,960-229-130-3,503-124
Cash from Financing Activity -350-4-69-1922586996-1,326-1302,929-928
Proceeds from borrowings54120129901382434271,6604901,3693,899750
Repayment of borrowings0-61-67-72-163-103-13-273-774-1,130-488-1,003
Investment subsidy000000100000
Interest paid fin-19-26-26-28-31-31-61-192-202-188-264-480
Dividends paid-0-33-41-59-137-83-267-200-840-204-265-310
Other financing items0010100102346115
Net Cash Flow123171165-7862-13370-3849319-349-69

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Ratios

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
ROCE %22%22%28%25%26%35%35%22%44%17%9%13%
Debtor Days747567717211014312461829586
Inventory Turnover5.586.506.766.135.635.064.834.706.214.553.644.34

Announcements & News

Recent Announcements

How to Invest in Mutual Funds SIP Online?

  1. Open Free Investment Account for Lifetime at Fincash.com.
  2. Complete your Registration and KYC Process
  3. Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest! Get Started
  4. Invest in Mutual Funds which invests in Torrent Pharmaceuticals Ltd & Get More Returns than Bank Deposit

Disclaimer:
All efforts have been made to ensure the information provided here is accurate as per time to time filling by company to exchanges. However, no guarantees are made regarding correctness of data. Investors are advised to validate/check information with exchanges or companies website before making any investment decisions.